(Q43600554)

English

The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylax

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

June-Won Cheong

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Jin Seok Kim

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Yeo-Kyeoung Kim

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Jinny Park

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Hye Jin Kang

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Hyeon Gyu Yi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Je-Hwan Lee

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Yang Soo Kim

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Hun-Mo Ryoo

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Sung-Hyun Kim

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Ho Young Kim

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Jin Young Kim

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Dong-Gun Lee

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Hoon-Gu Kim

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Hawk Kim

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Young-Don Joo

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

27 June 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Annals of Hematology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

93

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

33-42

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO).

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Empirical antifungal therapy in treating febrile neutropenic patients

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Empirical antifungal therapy in patients with neutropenia and persistent or recurrent fever of unknown origin

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Evidence-based guidelines for empirical therapy of neutropenic fever in Korea

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Intravenous itraconazole vs. amphotericin B deoxycholate for empirical antifungal therapy in patients with persistent neutropenic fever.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Antifungal serum concentration monitoring: an update

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Toxicodynamics of itraconazole: implications for therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Clinical significance of measuring the blood concentration of itraconazole oral solution in the field of hematology

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Population pharmacokinetics of intravenous itraconazole in patients with persistent neutropenic fever.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Hydroxy-itraconazole pharmacokinetics is similar to that of itraconazole in immunocompromised patients receiving oral solution of itraconazole

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Making sense of itraconazole pharmacokinetics

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1826-X

21 January 2018

Identifiers

10.1007/S00277-013-1826-X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23807252%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43600554&oldid=2101816957"